期刊文献+

Changes of Expressions of VEGF, bFGF, and Angiogenesis, and Effect of Benazepril, bFGF on Angiogenesis in Acute Myocardial Infarction Model of the Rabbits 被引量:12

Changes of Expressions of VEGF, bFGF, and Angiogenesis, and Effect of Benazepril, bFGF on Angiogenesis in Acute Myocardial Infarction Model of the Rabbits
下载PDF
导出
摘要 Objective To explore the changes of vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) and angiogenesis, and the effects of bFGF, angiotensin converting enzyme inhibiter(ACEI) benazepril on the angiogenesis in acute myocardial infarction (AMI) model of rabbits, and to provide a probable evidence for the treatment of AMI. Methods AMI model was established by ligating anterior descending branch of coronary artery of Japan-Sino hybridization white rabbits. The postoperative rabbits were randomly divided into 6 groups and each group was treated with different drugs. Groups 1 and 2 were treated with normal saline (NS) for 28 and 14 days (d), group 3 and 4 with bFGF for 28 and 14 d, groups 5 with benazepril for 14 d, and group 6 with benazepril and bFGF for 14 d respectively. The rabbits were killed on the 14th or 28th d and their hearts were excised, sectioned and stained with HE, Masson trichrome to observe VEGF, bFGF and CD34 under a microscope, which were quantified with a computer-assisted morphometry. Results Compared with group 1, the granulation tissue of infarction zone (IZ) in group 2 freshened up, and the capillary density (CD) in IZ was increased (P=0.002). The CD in the IZ as well as VEGF and bFGF in groups 3 and 4 were increased respectively (P=0.011-0.037). In group 5 the changes of VEGF and bFGF were not found in the IZ and the border zone (BZ) while CD was significantly increased (35.4% and 25.6%, P=0.036 and 0.037). Compared with group 2, the CD in the IZ and BZ of group 6 was significantly increased (63.4% and 44.3% P=0.007 and 0.007), meanwhile VEGF and bFGF were increased. Compared with group 5, only VEGF was increased. Conclusion Intravenous bFGF may increase VEGF and bFGF significantly, thus promoting the angiogenesis in the IZ and BZ in cardiac infarction as VEGF and bFGF are the potent angiogenic growth factors. Benazepril may promote angiogenesis in the IZ and BZ in cardiac infarction, but its mechanism is irrelative to the expression of VEGF and bFGF. The Objective To explore the changes of vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) and angiogenesis, and the effects of bFGF, angiotensin converting enzyme inhibiter(ACEI) benazepril on the angiogenesis in acute myocardial infarction (AMI) model of rabbits, and to provide a probable evidence for the treatment of AMI. Methods AMI model was established by ligating anterior descending branch of coronary artery of Japan-Sino hybridization white rabbits. The postoperative rabbits were randomly divided into 6 groups and each group was treated with different drugs. Groups 1 and 2 were treated with normal saline (NS) for 28 and 14 days (d), group 3 and 4 with bFGF for 28 and 14 d, groups 5 with benazepril for 14 d, and group 6 with benazepril and bFGF for 14 d respectively. The rabbits were killed on the 14th or 28th d and their hearts were excised, sectioned and stained with HE, Masson trichrome to observe VEGF, bFGF and CD34 under a microscope, which were quantified with a computer-assisted morphometry. Results Compared with group 1, the granulation tissue of infarction zone (IZ) in group 2 freshened up, and the capillary density (CD) in IZ was increased (P=0.002). The CD in the IZ as well as VEGF and bFGF in groups 3 and 4 were increased respectively (P=0.011-0.037). In group 5 the changes of VEGF and bFGF were not found in the IZ and the border zone (BZ) while CD was significantly increased (35.4% and 25.6%, P=0.036 and 0.037). Compared with group 2, the CD in the IZ and BZ of group 6 was significantly increased (63.4% and 44.3% P=0.007 and 0.007), meanwhile VEGF and bFGF were increased. Compared with group 5, only VEGF was increased. Conclusion Intravenous bFGF may increase VEGF and bFGF significantly, thus promoting the angiogenesis in the IZ and BZ in cardiac infarction as VEGF and bFGF are the potent angiogenic growth factors. Benazepril may promote angiogenesis in the IZ and BZ in cardiac infarction, but its mechanism is irrelative to the expression of VEGF and bFGF. The
出处 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 2004年第4期442-451,共10页 生物医学与环境科学(英文版)
关键词 Myocardial infarction ANGIOGENESIS Basic fibroblast growth factor Vascular endothelial growth factor BENAZEPRIL Myocardial infarction Angiogenesis Basic fibroblast growth factor Vascular endothelial growth factor Benazepril
  • 相关文献

参考文献30

  • 1[1]Rubanyi, G. M. (2001). The future of human gene therapy. Mol. Aspects. Med. 22, 113-142. 被引量:1
  • 2[2]Post, M. J., Laham, R., Sellke, F. W., and Simons, M. (2001). Therapeutic angiogenesis in cardiology using protein formulations. Cardiovasc. Res. 49, 522-531. 被引量:1
  • 3[3]Heba, G., Krzeminski, T., Porc, M., Grzyb, J., Ratajska, A., and Dembinska-Kiec, A. (2001). The time course of tumor necrosis factor-alpha, inducible nitric oxide syn myocardial infarction in rats. J. Vasc. Res. 38, 288-300. 被引量:1
  • 4[4]Cohen, N. Y., Vernon, J., Yaghdjian, V., and Hatcher, V. B. (1994). Longitudinal changes in myocardial basic fibroblast growth factor (FGF-2) activity following coronary artery ligation in the dog. J. Mol. Cell. Cardiol. 26, 683-690. 被引量:1
  • 5[5]Xie, Z. L., Gao, M., and Koyama,T. (1997) Effect of transient coronary occlusion on the capillary network in the left ventricle of rat. Jap. J. Physiol. 47, 537-543. 被引量:1
  • 6[6]Lopez, J. J., Edelman, E. R., Stamler, A., Hibberd, M. G., Prasad, P., Caputo, R. P., Carrozza, J. P., Douglas, P. S., Sellke, F. W., and Simons, M. (1997). Basic fibroblast growth factor in a porcine model of chronic myocardial ischemia: A comparision of angiographic echocardigraphic and coronary flow parameters. J. Pharm. Exp. Therap. 282, 385-390. 被引量:1
  • 7[7]Harada, K., Friedman, M., Lopez, J. J., Wang, S. Y., Li, J., Prasad, P. V., Pearlman, J. D., Edelman, E. R., Sellke, F. W., and Simons, M. (1996). Vascular endothelial growth factor administration in chronic myocardial ischemia. Am. J .Physiol. 270, 1791-1802. 被引量:1
  • 8[8]Mack, C. A., Patel, S. R., Schwarz, E. A., Zanzonico, P., Hahn, R. T., Ilercil, A., Devereux, R. B., Goldsmith, S. J., Christian, T. F., Sanborn, T. A., Kovesdi, I., Hackett, N., Isom, O. W., Crystal, R. G., and Rosengart, T. K. (1997). Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucliec acid for vascular endothelial growth factor 121 improves myocardiol perfusion and function in ischemic porcine heart. J. Thorac. Cardio. Surg. 115, 168-177. 被引量:1
  • 9[9]Kalkman, E. A., van Haren, P., Saxena, P. R., and Schoemaker, R. G. (1999). Early captopril prevents myocardial infarction-induced hypertrophy but not angiogenesis. Eur. J. Pharmacol. 369, 339-348. 被引量:1
  • 10[10]Olivetti, G., Cigola, E., Lagrasta, C., Ricci, R., Quaini, F., Monopoli, A., and Ongini, E. (1993). Spirapril prevents left ventricular hypertrophy, decreases myocardial damage and promotes angiogenesis in spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 21, 362-370. 被引量:1

同被引文献103

引证文献12

二级引证文献82

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部